Ki67 and breast cancer mortality in women with invasive breast cancer.

ABSTRACT:

Background

The percentage of cells staining positive for Ki67 is sometimes used for decision-making in patients with early invasive breast cancer (IBC). However, there is uncertainty regarding the most appropriate Ki67 cut points and the influence of interlaboratory measurement variability. We examined the relationship between breast cancer mortality and Ki67 both before and after accounting for interlaboratory variability and 8 patient and tumor characteristics.

Methods

A multicenter cohort study of women with early IBC diagnosed during 2009-2016 in more than 20 NHS hospitals in England and followed until December 31, 2020.

Results

Ki67 was strongly prognostic of breast cancer mortality in 8212 women with estrogen receptor (ER)-positive, human epidermal growth factor

SUBMITTER: Probert J 

PROVIDER: S-EPMC10500622 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature